Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain - Journal of Pain and Symptom Management
GW Pharma Extends Recruitment for Pivotal Trials of Sativex in MS
Everything you need to know about Sativex, the first cannabis-based drug to be globally standardised
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Nabiximols for Multiple Sclerosis Clinical Trial 2022 | Power
Nabiximols - Wikipedia
Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
Nabiximols in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial - The Lancet Neurology
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis | Neurodegenerative Disease Management
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
At Long Last Sativex? | O'Shaughnessy's
Jazz Says Cannabis-Derived Medicine Trial Missed Goals | Cannabis Equipment News
US FDA grants Sativex fast track status for cancer pain
What's Sativex And How Does It Differ From Medical Cannabis? - RQS Blog
Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial | Drug and Alcohol Research Connections
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
Sativex fails to meet primary end point in latest clinical trial
Life | Free Full-Text | The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms | HTML
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
ALS Spasticity May Ease with Use of Sativex, Cannabis Mouth Spray, Trial Reports
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
GW Pharma Phase 3 Trials for Sativex Miss Endpoints – New Cannabis Ventures
A double blind, randomised, placebo controlled trial of Sativex® for the management of cannabis withdrawal | NDARC - National Drug and Alcohol Research Centre
![PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ff46d50dfc6424b75848bde31bd6ab11bd240824/3-Figure1-1.png "PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar")
PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar
Sativex fails to meet primary end point in latest clinical trial
